Background
Cardiac arrest causes primary and secondary brain injuries. We aimed to evaluate the association between neuron-specific enolase (NSE), serum S-100B (S100B), electroencephalogram (EEG) patterns, and post-cardiac arrest outcomes, including arrest duration and survival, in pediatric patients.
Methods
This prospective observational study was conducted in the pediatric intensive care unit of our hospital from January 2017 to December 2019 and included 41 post-cardiac arrest patients with different etiologies who underwent EEG and serum sampling for NSE and S100B. The participants were aged 1 month to 18 years who experienced cardiac arrest and underwent cardiopulmonary resuscitation after a sustained return of spontaneous circulation for ≥48 hours. We excluded immunocompromised patients, those with neurological diseases, hematological malignancies or solid tumors, or a history of head trauma.
Results
Approximately 19.5% (n=8) of patients survived until hospital discharge. Convulsions and sepsis—observed in 21.9% (n=9) and 82.9% (n=34) of patients, respectively—were significantly associated with higher mortality (relative risk: 1.33 [95% CI=1.09–1.6] and 1.99 [95% CI=0.8–4.7], respectively). Serum NSE and S100B levels were not statistically associated with outcome (P=0.278 and 0.693, respectively). NSE levels were positively correlated with arrest duration. EEG patterns were significantly associated with outcome (P=0.01). Non-epileptogenic EEG activity was associated with the highest survival rate. No patient with burst suppression survived.
Conclusion
Post-cardiac arrest syndrome is a serious condition with a high mortality rate. Management of sepsis and convulsions affects prognosis. NSE and S100B have no benefit in survival evaluation. EEG is recommended for all post-cardiac arrest patients.